Publications by authors named "Qiuwen Lou"

The raphe nuclei, the primary resource of forebrain 5-HT, play an important but heterogeneous role in regulating subcortical excitabilities. Fundamental circuit organizations of different median raphe (MR) subsystems are far from completely understood. In the present study, using cell-specific viral tracing, Ca fiber photometry and epilepsy model, we map out the forebrain efferent and afferent of different MR Pet subpopulations and their divergent roles in epilepsy.

View Article and Find Full Text PDF

The raphe nuclei comprise nearly all of 5-hydroxytryptaminergic (5-HTergic) neurons in the brain and are widely acknowledged to participate in the modulation of neural excitability. "Excitability-inhibition imbalance" results in a variety of brain disorders, including epilepsy. Epilepsy is a common neurological disorder characterized by hypersynchronous epileptic seizures accompanied by many psychological, social, cognitive consequences.

View Article and Find Full Text PDF

Epilepsy is a circuit-level brain disorder characterized by hyperexcitatory seizures with unclear mechanisms. Here, we investigated the causal roles of calretinin (CR) neurons in the posterior intralaminar thalamic nucleus (PIL) in hippocampal seizures. Using c-fos mapping and calcium fiber photometry, we found that PIL CR neurons were activated during hippocampal seizures in a kindling model.

View Article and Find Full Text PDF

Loofah seeds ribosome inactivating protein luffin-α was fused with a tumor-targeting peptide NGR to create a recombinant protein, and its inhibitory activity on tumor cells and angiogenesis were assessed. fusion gene was obtained by PCR amplification. The fusion gene was ligated with pGEX-6p-1 vector to create a recombinant plasmid pGEX-6p-1/.

View Article and Find Full Text PDF
Article Synopsis
  • MAP30 is a 30kD antiviral protein known for its anti-tumor properties, specifically showing promise as a treatment for liver cancer.
  • Researchers genetically modified MAP30 with two tumor-targeting peptides (RGD and EGFRi) to create a more effective version called rELRL-MAP30, which was successfully produced in E. coli.
  • rELRL-MAP30 demonstrated significant cytotoxic effects on liver cancer cells, inhibiting their growth, inducing apoptosis, and preventing cell migration more effectively than the original MAP30 protein.
View Article and Find Full Text PDF